Hepion Pharmaceuticals, Inc. (NASDAQ: HEPA), a clinical stage biopharmaceutical company that has been developing a treatment ...

Meet Tom Nash and his dog Caesar. “He has separation anxiety, and likes to be draped around my shoulders like a scarf – he’ll ...

Medically reviewed by Qin Rao, MD Metabolic dysfunction-associated steatohepatitis (MASH) is a disease that occurs when ...

The YMCA of Pierce and Kitsap County have partnered with VMFH to refer patients into medically tailored programs at the gym.

Medically reviewed by Qin Rao, MD Metabolic dysfunction-associated steatohepatitis (MASH)—previously known as nonalcoholic ...

Dave Weldon, President Trump’s nominee to run the Centers for Disease Control and Prevention (CDC), told a top Democratic senator that he believes there’s a link between vaccines and autism, and ...

NAFLD, the most prevalent liver disease, affects approximately 25% of the global population (1.2 billion people), including 188 million in India. Left untreated, NAFLD can progress to non-alcoholic ...

The liver is essential for digestion, metabolism, detoxification, and fluid regulation. While alcohol abuse is a known cause ...

Researchers at Georgetown University have developed a new drug called CTPI-2, which targets a key gene known as Slc25a1. This ...

Investigators have found that the gene Asah1 plays a crucial protective role in preventing the progression of nonalcoholic ...

Investigators have found that the gene Asah1 plays a crucial protective role in preventing the progression of nonalcoholic ...

NASH, the more severe form of NAFLD ... with over 50,000 active subscribers. "Non-alcoholic fatty liver disease impacts over 100 million Americans, and as part of our mission to develop life-changing ...